Arántzazu Barquín
Universidad San Pablo CEU(ES)Centro Oncológico de Galicia(ES)HM Hospitales(ES)Hospital Universitario HM Sanchinarro(ES)Camilo José Cela University(ES)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, PARP inhibition in cancer therapy, Cancer Immunotherapy and Biomarkers, Colorectal Cancer Surgical Treatments, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → Impact of the combination of durvalumab (MEDI4736) plus olaparib (AZD2281) administered prior to surgery in the molecular profile of resectable urothelial bladder cancer: NEODURVARIB Trial.(2020)43 cited
- → The efficacy and safety of mirvetuximab soravtansine in FRα-positive, third-line and later, recurrent platinum-sensitive ovarian cancer: the single-arm phase II PICCOLO trial(2024)31 cited
- → New oncologic emergencies: What is there to know about inmunotherapy and its potential side effects?(2019)26 cited
- → p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study(2023)23 cited
- → MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma(2021)22 cited
- → Proteomic profiles of peritoneal fluid-derived small extracellular vesicles correlate with patient outcome in ovarian cancer